Mitochondrial dysfunction and Alzheimer's disease

被引：94
|
作者：
Maruszak, Aleksandra [1 ]
Zekanowski, Cezary [1 ]
机构：
[1] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurodegenerat Disorders, PL-02106 Warsaw, Poland
来源：
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 2011年 / 35卷 / 02期
关键词：
Alzheimer's disease; APOE4; Mitochondrial DNA (mtDNA); Mitochondrial dysfunction; Mitochondrial haplogroups; Oxidative stress; CYTOCHROME-C-OXIDASE; AMYLOID PRECURSOR PROTEIN; KETOGLUTARATE DEHYDROGENASE COMPLEX; OXIDATIVELY MODIFIED PROTEINS; MILD COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E GENOTYPE; OXYGEN SPECIES PRODUCTION; MATERNAL FAMILY-HISTORY; FREE-RADICAL GENERATION; MTDNA CONTROL-REGION;
D O I：
10.1016/j.pnpbp.2010.07.004
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
To date, one of the most discussed hypotheses for Alzheimer's disease (AD) etiology implicates mitochondrial dysfunction and oxidative stress as one of the primary events in the course of AD. In this review we focus on the role of mitochondria and mitochondrial DNA (mtDNA) variation in AD and discuss the rationale for the involvement of mitochondrial abnormalities in AD pathology. We summarize the current data regarding the proteins involved in mitochondrial function and pathology observed in AD, and discuss the role of somatic mutations and mitochondrial haplogroups in AD development. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码：320 / 330
页数：11
相关论文
共 50 条
  • [1] MITOCHONDRIAL DYSFUNCTION IN ALZHEIMER'S DISEASE
    Kota, Lakshmi Narayanan
    Nayak, Rashmitha
    Paul, Pradip
    Viswanath, Biju
    Varghese, Mathew
    Jain, Sanjeev
    Purushottam, Meera
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S840 - S841
  • [2] Mitochondrial dysfunction and Alzheimer's disease
    Ghosh, SS
    Miller, S
    Herrnstadt, C
    Fahy, E
    Shinobu, LA
    Galasko, D
    Thal, LJ
    Beal, MF
    Howell, N
    Parker, WD
    Davis, RE
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 59 - 66
  • [3] Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease
    Cadonic, Chris
    Sabbir, Mohammad Golam
    Albensi, Benedict C.
    MOLECULAR NEUROBIOLOGY, 2016, 53 (09) : 6078 - 6090
  • [4] Metabolomics and mitochondrial dysfunction in Alzheimer's disease
    Kim, Dong Hee
    Gim, Jeong-An
    Yoon, Dahye
    Kim, Suhkmann
    Kim, Heui-Soo
    GENES & GENOMICS, 2017, 39 (03) : 295 - 300
  • [5] Mitochondrial aging and dysfunction in Alzheimer's disease
    Sullivan, PG
    Brown, MR
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (03): : 407 - 410
  • [6] Mitochondrial dysfunction in models of Alzheimer's disease
    Eckert, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 23 - 23
  • [7] Metabolomics and mitochondrial dysfunction in Alzheimer’s disease
    Dong Hee Kim
    Jeong-An Gim
    Dahye Yoon
    Suhkmann Kim
    Heui-Soo Kim
    Genes & Genomics, 2017, 39 : 295 - 300
  • [8] Role of mitochondrial dysfunction in Alzheimer's disease
    Castellani, R
    Hirai, K
    Aliev, G
    Drew, KL
    Nunomura, A
    Takeda, A
    Cash, AD
    Obrenovich, ME
    Perry, G
    Smith, MA
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (03) : 357 - 360
  • [9] Mechanisms of Mitochondrial Dysfunction in Alzheimer’s Disease
    Chris Cadonic
    Mohammad Golam Sabbir
    Benedict C. Albensi
    Molecular Neurobiology, 2016, 53 : 6078 - 6090
  • [10] Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease
    Onyango, Isaac
    Khan, Shaharyar
    Miller, Bradley
    Swerdlow, Russell
    Trimmer, Patricia
    Bennett, James, Jr.
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 9 (02) : 183 - 193
12345